Building for better bones: evaluation of a clinical pathway in the secondary prevention of osteoporotic fractures

Eur J Hosp Pharm. 2018 Jul;25(4):210-213. doi: 10.1136/ejhpharm-2016-000906. Epub 2016 Sep 6.

Abstract

Objective: Osteoporosis is a common disease that is underdiagnosed and undertreated. A multidisciplinary intervention may improve the identification and treatment of osteoporosis and may consequently prevent secondary fractures.

Method: Retrospective, single-centre study comparing attitude to screening and treatment of patients admitted to the orthopaedic unit of the general hospital AZ Sint-Jan Brugge-Oostende AV (Belgium) before and after the implementation of a clinical pathway.

Results: A total of 172 patients (86 before and 86 after) were included in this study. The implementation of the pathway resulted in an increase in bone mineral density tests performed, an increment in the number of referrals to a specialist in the field of osteoporosis, and an increase in prevention and treatment of osteoporosis.

Conclusion: The implementation of a clinical pathway coordinated and evaluated by a clinical pharmacist improved the identification, referral and treatment of osteoporosis in patients hospitalised due to low-impact fractures.

Keywords: CLINICAL PHARMACY; PHARMACOTHERAPY; PREVENTIVE MEDICINE; PRIMARY CARE; RHEUMATOLOGY.